This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Voliva, C F Articles by Peterlin, B M Search for Related Content PubMed PubMed Citation Articles by Voliva, C F Articles by Peterlin, B M

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 May; 12(5): 2383-2390

B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Howard Hughes Medical Institute, University of California, San Francisco 94143-0724.

ABSTRACT

The X box in the DRA promoter of the human histocompatibility complex is required for expression of the DRA gene in B cells. We show that a B-cell factor binds to a sequence that is clearly distinguishable from binding sites for the previously described X box binding nuclear proteins RF-X, NF-X, NF-Xc, NF-S, hXBP, and AP-1. Mutations in the DRA X box that disrupt the binding of this factor result in a lower level of gene expression, as does the presence of Id (a trans-dominant regulatory protein that negatively regulates helix-loop-helix proteins). Furthermore, this factor is recognized by antibodies directed against the helix-loop-helix protein A1, a mouse homolog of the immunoglobulin enhancer binding proteins E12/E47, and it binds to sequences in other genes that were previously shown to bind these proteins. By these criteria, this factor is BCF-1.

This article has been cited by other articles:

• Girdlestone, J. (2000). Synergistic induction of HLA class I expression by RelA and CIITA. Blood 95: 3804-3808 [Abstract] [Full Text]  
• David, E., Garcia, A. D., Hearing, P. (1995). Interaction of EF-C/RFX-1 with the Inverted Repeat of Viral Enhancer Regions Is Required for Transactivation. J. Biol. Chem. 270: 8353-8360 [Abstract] [Full Text]